Dyne Therapeutics Inc
NASDAQ:DYN
Dyne Therapeutics Inc
NASDAQ:DYN
Price:
17.09
USD
-0.29%
Market Closed
Market Cap:
$2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dyne Therapeutics Inc
NASDAQ:DYN
|
US |
|
Sunyes Electronic Manufacturing Guangdong Holding Co Ltd
SZSE:002388
|
CN |
|
C
|
CD Projekt SA
WSE:CDR
|
PL |
|
E
|
Empresas Hites SA
SGO:HITES
|
CL |
|
T
|
Tianli Holdings Group Ltd
HKEX:117
|
HK |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
Zhuzhou Huarui Precision Cutting Tools Co Ltd
SSE:688059
|
CN |
|
P
|
Paragon Globe Bhd
KLSE:PARAGON
|
MY |
|
G
|
Grupo Supervielle SA
BCBA:SUPV
|
AR |
|
E
|
Exel Composites Oyj
OMXH:EXL1V
|
FI |
|
Autel Intelligent Technology Corp Ltd
SSE:688208
|
CN |
|
Anfu CE LINK Ltd
SZSE:300787
|
CN |
|
Novorossiyskiy Kombinat Khleboproduktov PAO
MOEX:NKHP
|
RU |
|
EUDA Health Holdings Ltd
NASDAQ:EUDA
|
SG |
|
A
|
APact Co Ltd
KOSDAQ:200470
|
KR |
|
W
|
Wuxi Online Offline Communication Information Technology Co Ltd
SZSE:300959
|
CN |
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
CN |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
IN |
|
SICHUAN HZ-YEG MEDICAL Co Ltd
SZSE:300937
|
CN |
|
Titan International Inc
NYSE:TWI
|
US |
|
Kelsian Group Ltd
ASX:KLS
|
AU |
Balance Sheet
Balance Sheet Decomposition
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet Decomposition is not available for
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
893
|
|
| Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
893
|
|
| Short-Term Investments |
0
|
0
|
45
|
176
|
84
|
1
|
207
|
217
|
|
| Other Current Assets |
0
|
0
|
4
|
6
|
10
|
6
|
17
|
16
|
|
| Total Current Assets |
8
|
15
|
349
|
382
|
266
|
129
|
659
|
1 127
|
|
| PP&E Net |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
45
|
|
| PP&E Gross |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
45
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
5
|
7
|
9
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
2
|
2
|
2
|
2
|
16
|
|
| Total Assets |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
1 187
+72%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
3
|
4
|
5
|
23
|
7
|
8
|
|
| Accrued Liabilities |
0
|
1
|
8
|
25
|
23
|
28
|
36
|
43
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
11
|
29
|
28
|
51
|
42
|
51
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
149
|
|
| Other Liabilities |
3
|
0
|
0
|
29
|
26
|
23
|
19
|
15
|
|
| Total Liabilities |
4
N/A
|
2
-41%
|
11
+358%
|
58
+423%
|
54
-6%
|
74
+37%
|
61
-17%
|
215
+250%
|
|
| Equity | |||||||||
| Common Stock |
9
|
27
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
20
|
79
|
229
|
397
|
633
|
950
|
1 396
|
|
| Additional Paid In Capital |
0
|
6
|
422
|
597
|
650
|
724
|
1 580
|
2 368
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
14
+233%
|
342
+2 346%
|
368
+8%
|
252
-31%
|
91
-64%
|
630
+590%
|
972
+54%
|
|
| Total Liabilities & Equity |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
1 187
+72%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
44
|
44
|
45
|
52
|
56
|
61
|
102
|
165
|
|
Switch to:
Switch to:
See Also
Discover More
